Circulating exo-miRNA-27a-5p is a novel biomarker of the tofacitinib treatment response in rheumatoid arthritis
Abstract Background Effective biological markers able to monitor the response of Janus kinase inhibitor (JAKi) are lacking. Exosomal microRNAs (exomiRNAs) can alter their expression during treatment and are ideal biomarkers for therapeutic interventions. In this study, we explored potential biomarke...
Saved in:
| Main Authors: | Jiwei Zhao, Tianjun Zhu, Qiu Liao, Jijia Sun, Fuqun Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Rheumatology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41927-025-00502-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential MiRNA therapies for premature ovarian failure: new challenges and opportunities
by: Wang Xinyue, et al.
Published: (2025-07-01) -
Progress in understanding the role and mechanism of miRNAs in osteoporosis
by: Feifei Meng, et al.
Published: (2025-08-01) -
Cyclodextrin host-guest complexes-derived exosomal miRNAs for enhancing the antifatigue effects of resveratrol
by: Hurong Ge, et al.
Published: (2025-06-01) -
Exosome-Derived miRNAs in Liquid Biopsy for Lung Cancer
by: Israel Martínez-Espinosa, et al.
Published: (2024-12-01) -
Precise prediction of bone metastases and metastatic burden using exosomal mirnas and radiomics: a multi-center study
by: Chao Wang, et al.
Published: (2025-06-01)